I would say it's important to have a certain degree of duplication because, very often, the strains are not exactly the same. They are just as likely to have unique characteristics in the U.S. as they are in Canada. Even within Canada, ticks out west aren't exactly the same ticks that we have out east. Hence the importance of validating the approach.
Much of the research focus has been on vaccines, but prevention is another important area of research, which I mentioned. And in that connection, the idea is to reduce the number of bites, the number of ticks and even the number of animals that are carriers of the disease. That means prevention mechanisms. And the same is happening on the American side. The research being done covers a rather broad spectrum. As I said, the U.S. has been dealing with Lyme disease longer than we have, and that explains why they have been able to make progress a bit faster than we have. Nevertheless, I can tell you that the calibre of research being done in Canada is world-class.